YD Bio Limited (NASDAQ:YDES – Get Free Report) shares were down 9.9% during mid-day trading on Thursday . The stock traded as low as $11.03 and last traded at $11.03. Approximately 58,150 shares traded hands during mid-day trading, a decline of 3% from the average daily volume of 59,873 shares. The stock had previously closed at $12.24.
Analysts Set New Price Targets
YDES has been the subject of several research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen upgraded shares of YD Bio to a “sell” rating in a research report on Tuesday, November 4th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on YDES
YD Bio Trading Down 9.9%
YD Bio Company Profile
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
See Also
- Five stocks we like better than YD Bio
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- Buy This Stock at 9:30 AM on MONDAY!
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
